INKT · MiNK Therapeutics, Inc. · Fails to Deliver
$12.73
+0.18 (+1.43%)
At close · Oct 1
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the completion of anticipated funding is not entirely within the Company's control, the Company is required to disclose that substantial doubt exists about its ability to continue as a going concern for a period of one year after the date of filing of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 13, 2026
Market Cap
$62.15M
Shares
5.10M
Volume · Oct 1
26.68K
Avg daily vol (3M)
13.03K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-14 | 10 | $12.20 | $122 |
| 2026-09-09 | 57 | $11.45 | $653 |
| 2026-09-08 | 65 | $11.64 | $757 |
| 2026-09-04 | 83 | $11.23 | $932 |
| 2026-09-03 | 592 | $11.33 | $6,707 |
| 2026-09-01 | 240 | $11.09 | $2,662 |
| 2026-08-24 | 955 | $12.20 | $11,651 |
| 2026-08-19 | 25 | $11.86 | $297 |
| 2026-08-14 | 28 | $11.00 | $308 |
| 2026-08-13 | 197 | $11.36 | $2,238 |
| 2026-08-12 | 142 | $11.15 | $1,583 |
| 2026-08-10 | 39 | $10.95 | $427 |
| 2026-08-05 | 522 | $11.07 | $5,779 |
| 2026-08-04 | 33 | $10.69 | $353 |
| 2026-07-28 | 363 | $10.71 | $3,888 |
| 2026-07-27 | 564 | $11.07 | $6,243 |
| 2026-07-24 | 7 | $10.37 | $73 |
| 2026-07-20 | 380 | $10.66 | $4,051 |
| 2026-07-17 | 272 | $10.81 | $2,940 |
| 2026-07-15 | 20 | $11.41 | $228 |
| 2026-07-14 | 262 | $11.15 | $2,921 |
| 2026-07-10 | 546 | $11.46 | $6,257 |
| 2026-07-02 | 36 | $11.46 | $413 |
Showing 1–23 of 23 settlements